Alzheimer's disease

A new market beckons for Alzheimer’s blood tests
A new market beckons for Alzheimer’s blood tests
EP Vantage
Alzheimer's disease
diagnostics
donanemab
Eli Lilly
Biogen
Quanterix
Flag link:
FDA grew too close to Biogen during Alzheimer’s drug development, doctors say
FDA grew too close to Biogen during Alzheimer’s drug development, doctors say
Pharmaforum
FDA
Biogen
drug development
aducanumab
Alzheimer's disease
Flag link:
FDA advisers reassert case against approval of Biogen's Alzheimer's drug
FDA advisers reassert case against approval of Biogen's Alzheimer's drug
BioPharma Dive
Biogen
FDA
Alzheimer's disease
aducanumab
Flag link:
Biogen's Aducanumab: A Look at the Drug’s History and Recent Updates
Biogen's Aducanumab: A Look at the Drug’s History and Recent Updates
BioSpace
Biogen
Eisai
aducanumab
Alzheimer's disease
Flag link:
Partner Therapeutics’ Leukine Shows Promise for Alzheimer’s in New Study
Partner Therapeutics’ Leukine Shows Promise for Alzheimer’s in New Study
BioSpace
Partner Therapeutics
Leukine
clinical trials
Alzheimer's disease
Flag link:
Will Another Alzheimer's Disease Drug Bite the Dust After Lilly's Latest Results?
Will Another Alzheimer's Disease Drug Bite the Dust After Lilly's Latest Results?
Motley Fool
Eli Lilly
Alzheimer's disease
donanemab
Flag link:
Big pharma’s key catalysts in the second quarter
Big pharma’s key catalysts in the second quarter
EP Vantage
Biogen
Alzheimer's disease
aducanumab
Sanofi
breast cancer
FDA
Flag link:
Biogen outlines 10M-patient opportunity for Alzheimer's drug in US
Biogen outlines 10M-patient opportunity for Alzheimer's drug in US
Biopharma Reporter
Biogen
Alzheimer's disease
aducanumab
Flag link:
Lilly lays out 2-year plan to gain approval for Alzheimer's drug
Lilly lays out 2-year plan to gain approval for Alzheimer's drug
BioPharma Dive
Eli Lilly
donanemab
clinical trials
Alzheimer's disease
Flag link:
Why Eli Lilly's Successful Alzheimer's Disease Study Was So Disappointing
Why Eli Lilly's Successful Alzheimer's Disease Study Was So Disappointing
Motley Fool
Eli Lilly
Alzheimer's disease
clinical trials
donanemab
Flag link:
Clinical Trial Begins For Gene Therapy To Treat Alzheimer’s Disease
Clinical Trial Begins For Gene Therapy To Treat Alzheimer’s Disease
Forbes
gene therapy
UCSD
Alzheimer's disease
clinical trials
Flag link:
Lilly lines up its next shot at Alzheimer’s
Lilly lines up its next shot at Alzheimer’s
EP Vantage
Eli Lilly
donanemab
Alzheimer's disease
Flag link:
New Drug Approval Could Be on Horizon for Alzheimer’s after 17-Year Drought
New Drug Approval Could Be on Horizon for Alzheimer’s after 17-Year Drought
BioSpace
Alzheon
Alzheimer's disease
ALZ-801
Flag link:
AI uncovers Eli Lilly's rheumatoid arthritis drug Olumiant as potential Alzheimer's treatment
AI uncovers Eli Lilly's rheumatoid arthritis drug Olumiant as potential Alzheimer's treatment
Fierce Biotech
Eli Lilly
olumiant
JAK inhibitors
artificial intelligence
Alzheimer's disease
Flag link:
Where Will Biogen Be in 5 Years?
Where Will Biogen Be in 5 Years?
Motley Fool
Biogen
aducanumab
Alzheimer's disease
Flag link:
A safer Alzheimer's drug than Biogen's aducanumab? Denali-WashU drug shows better profile in mice
A safer Alzheimer's drug than Biogen's aducanumab? Denali-WashU drug shows better profile in mice
Fierce Biotech
Alzheimer's disease
Denali Therapeutics
Biogen
aducanumab
HAE-4
Flag link:
Pfizer, Verily-backed Alzheimer's biotech Cortexyme hit by FDA partial hold over liver toxicity
Pfizer, Verily-backed Alzheimer's biotech Cortexyme hit by FDA partial hold over liver toxicity
Fierce Biotech
Cortexyme
FDA
Pfizer
Verily
Alzheimer's disease
COR388
Flag link:
AC Immune has 'remarkable' Alzheimer's vaccine data. Just don't ask to see them
AC Immune has 'remarkable' Alzheimer's vaccine data. Just don't ask to see them
Endpoints
AC Immune
Alzheimer's disease
vaccines
clinical trials
Flag link:
Roche refreshingly cautious on Alzheimer's hopeful gantenerumab amid growing hype from rivals
Roche refreshingly cautious on Alzheimer's hopeful gantenerumab amid growing hype from rivals
Fierce Biotech
Roche
gantenerumab
Alzheimer's disease
Flag link:
Biogen laser-focused on Alzheimer's drug as rest of business falters
Biogen laser-focused on Alzheimer's drug as rest of business falters
BioPharma Dive
Biogen
earnings
aducanumab
Alzheimer's disease
Flag link:

Pages